Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLB
CLB logo

CLB Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
13.590
Open
13.440
VWAP
13.28
Vol
486.82K
Mkt Cap
605.25M
Low
13.110
Amount
6.46M
EV/EBITDA(TTM)
10.33
Total Shares
46.10M
EV
703.15M
EV/OCF(TTM)
20.48
P/S(TTM)
1.17
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
Show More

Events Timeline

(ET)
2026-04-29
17:00:00
Core Lab Q1 Revenue at $121.8M, Below Consensus
select
2026-04-29
17:00:00
Sees Q2 Revenue of $123M-$131M
select
2026-03-24 (ET)
2026-03-24
16:20:00
Major Averages Close Lower as Oil Surges Above $90
select
2026-03-24
12:00:00
Dow Jones Up 0.31% to 46,350.65 Points
select
2026-03-23 (ET)
2026-03-23
19:20:00
Trump Postpones Strikes on Iranian Energy, Market Sentiment Improves
select
2026-03-23
17:10:00
Core Lab Lowers Q1 Revenue Guidance to $119M-$123M
select
2026-03-23
17:10:00
Core Laboratories Shares Down 5% to $16.00 After Q1 Pre-Announcement
select
2026-02-04 (ET)
2026-02-04
17:20:00
Core Lab Reports Q4 Revenue of $138.3M
select
2026-02-04
17:20:00
Sees Q1 Revenue of $124M-$130M
select

News

Yahoo Finance
9.5
05-03Yahoo Finance
Core Laboratories Shares Drop 7.4% After Disappointing Q1 2026 Results
  • Significant Earnings Decline: Core Laboratories reported Q1 earnings per share of $0.06, a 76.92% miss from the expected $0.26, indicating a substantial drop in profitability that could undermine investor confidence.
  • Revenue Continues to Fall: The company's revenue for the quarter was $121.8 million, reflecting a 12% sequential decline and a 1% year-over-year decrease, suggesting weak market demand and operational challenges that may lead to downward revisions in future earnings expectations.
  • External Factors Impacting Performance: Severe cold weather in North America and a storm in the Mediterranean disrupted client activities and temporarily closed manufacturing facilities, exacerbating revenue and profit margin pressures, highlighting the company's vulnerability to natural disasters.
  • Increased Stock Volatility: Core Laboratories has experienced 25 moves greater than 5% over the past year, and while the current stock drop is significant, the market's perception of its long-term outlook may not fundamentally change, prompting investors to carefully assess buying opportunities.
Yahoo Finance
9.5
05-02Yahoo Finance
Core Laboratories Q1 Results Exceed Expectations Despite Sales Decline
  • Performance Overview: Core Laboratories reported Q1 CY2026 revenue of $121.8 million, slightly exceeding analyst expectations of $121 million, but reflecting a 1.4% year-on-year decline, indicating challenges in the market.
  • Profit Decline: The adjusted EPS of $0.06 fell significantly short of the $0.11 expected by analysts, representing a 45.5% miss, which highlights the pressure and rising costs faced by the company in its operations.
  • Market Environment Impact: Disruptions from the Middle East conflict and severe weather in North America and Europe led to project delays and reduced client activity, particularly affecting the Reservoir Description segment, with the CEO noting a situation of “all costs and no revenue.”
  • Future Outlook: Despite ongoing supply chain volatility and rising raw material costs, management anticipates a gradual recovery in client activity as geopolitical conditions stabilize, driving increased demand for reservoir diagnostics and production optimization technologies.
seekingalpha
9.5
04-30seekingalpha
Core Laboratories Q1 2026 Earnings Call Insights
  • Revenue Decline: Core Laboratories reported Q1 revenue of $121.8 million, reflecting a 12% decrease from the previous quarter and a 1% year-over-year decline, indicating significant business disruption due to the Middle East conflict, prompting a downward revision of the 2026 Q1 revenue and earnings forecast.
  • Shareholder Returns: Despite challenges, the company returned cash to shareholders through quarterly dividends and repurchased over 51,000 shares valued at $900,000, demonstrating a continued commitment to shareholder interests amid operational difficulties.
  • Future Outlook: Management projects Q2 2026 revenue to range between $123 million and $131 million, maintaining a cautiously optimistic view on gradual operational improvement despite geopolitical uncertainties impacting forecasting accuracy.
  • Operational Risks: Executives highlighted that the volatility and unpredictability of the conflict will affect operations, particularly regarding rising raw material costs and supply chain disruptions, which could lead to demand uncertainties and operational inefficiencies.
NASDAQ.COM
2.0
04-30NASDAQ.COM
Core Lab (CLB) Q1 2026 Earnings Transcript
seekingalpha
8.0
04-30seekingalpha
Core Laboratories Declares Quarterly Dividend of $0.01
  • Quarterly Dividend Declaration: Core Laboratories has declared a quarterly dividend of $0.01 per share, consistent with previous distributions, indicating the company's stability in the current economic climate.
  • Dividend Yield: The forward yield stands at 0.23%, which, while relatively low, still provides some cash return to investors, reflecting the company's ongoing commitment to its shareholders.
  • Payment Schedule: The dividend will be payable on June 1, with a record date of May 11 and an ex-dividend date also on May 11, ensuring shareholders receive their returns in a timely manner.
  • Market Reaction: Despite the unchanged dividend, market sentiment towards Core Laboratories remains cautious, particularly following the downward revision of Q1 guidance due to the impact of the Middle East conflict, which may affect future dividend policies.
seekingalpha
9.5
04-29seekingalpha
Core Laboratories Reports Q1 Earnings Miss
  • Disappointing Performance: Core Laboratories reported a non-GAAP EPS of $0.06 for Q1, missing expectations by $0.05, indicating ongoing pressure on profitability that may undermine investor confidence.
  • Revenue Decline: The company's revenue for Q1 was $121.8 million, down 1.4% year-over-year and missing expectations by $3.13 million, reflecting challenges from weak market demand and increased competition.
  • Margin Concerns: Despite the revenue drop, the company's profit margins remain too small, leading analysts to suggest that this could dampen investor excitement about future growth, potentially impacting stock performance.
  • Guidance Revision: Core Laboratories has cut its Q1 guidance, citing the impact of the Middle East war, indicating that external factors are negatively affecting operations and may heighten market concerns regarding future performance.
Wall Street analysts forecast CLB stock price to rise
1 Analyst Rating
Wall Street analysts forecast CLB stock price to rise
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 0.000
sliders
Low
11.50
Averages
11.50
High
11.50
Current: 0.000
sliders
Low
11.50
Averages
11.50
High
11.50
Stifel
Hold
downgrade
$13 -> $12
AI Analysis
2025-07-16
Reason
Stifel
Price Target
$13 -> $12
AI Analysis
2025-07-16
downgrade
Hold
Reason
Stifel lowered the firm's price target on Core Laboratories to $12 from $13 and keeps a Hold rating on the shares. Oil service stocks have underperformed the S&P 500 in 2025, and catalysts have been largely negative, the analyst tells investors in a research note. Entering Q2 earnings season, the firm believes shares will be range bound until estimates stop falling.
Citi
Neutral
downgrade
$16 -> $13
2025-05-13
Reason
Citi
Price Target
$16 -> $13
2025-05-13
downgrade
Neutral
Reason
Citi lowered the firm's price target on Core Laboratories to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLB
Unlock Now

Valuation Metrics

The current forward P/E ratio for Core Laboratories Inc (CLB.N) is 17.18, compared to its 5-year average forward P/E of 24.83. For a more detailed relative valuation and DCF analysis to assess Core Laboratories Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
24.83
Current PE
17.18
Overvalued PE
33.99
Undervalued PE
15.67

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.07
Current EV/EBITDA
27.17
Overvalued EV/EBITDA
19.65
Undervalued EV/EBITDA
10.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.86
Current PS
1.14
Overvalued PS
2.48
Undervalued PS
1.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

top aftermarket movers
Intellectia · 6 candidates
Market Cap: >= 100.00MRegion: USPrice: $0.50 - $1000.00List Exchange: XNYS, XNAS, XASEPost Market Price Change: $-100.00 - $-3.00Post Market Dollar Volume: >= 20,000
Ticker
Name
Market Cap$
top bottom
CLB logo
CLB
Core Laboratories Inc
754.79M
BATL logo
BATL
Battalion Oil Corp
232.77M
KNOP logo
KNOP
Knot Offshore Partners LP
317.61M
CNDT logo
CNDT
Conduent Inc
185.65M
LPL logo
LPL
LG Display Co Ltd
4.02B
NC logo
NC
NACCO Industries Inc
366.18M
so what Company is best for me
Intellectia · 79 candidates
Price: $5.00 - $400.00Relative Vol: >= 3List Exchange: XNYS, XNAS, XASEOne Week Rise Prob: >= 65One Week Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ITGR logo
ITGR
Integer Holdings Corp
3.00B
VERX logo
VERX
Vertex Inc
2.12B
SCHW logo
SCHW
Charles Schwab Corp
164.81B
SPHR logo
SPHR
Sphere Entertainment Co
3.95B
IRON logo
IRON
Disc Medicine Inc
2.42B
CRI logo
CRI
Carter's Inc
1.55B
Show stocks with the a b c d pattern
Intellectia · 40 candidates
Market Cap: <= 2.00BPrice: <= $20.00Relative Vol: >= 1.50Support Resistance Relationship: PriceAroundResistanceShares Outstanding: <= 50,000,000
Ticker
Name
Market Cap$
top bottom
CLB logo
CLB
Core Laboratories Inc
909.38M
ANSC logo
ANSC
Agriculture & Natural Solutions Acquisition Corp
465.74M
VHI logo
VHI
Valhi Inc
409.25M
NPAC logo
NPAC
New Providence Acquisition Corp III
395.43M
CCIX logo
CCIX
Churchill Capital Corp IX
391.19M
GPAT logo
GPAT
GP-Act III Acquisition Corp
385.25M

Whales Holding CLB

T
Tontine Management, LLC
Holding
CLB
+32.41%
3M Return
D
Disciplined Growth Investors, Inc.
Holding
CLB
+13.09%
3M Return
C
CWA Asset Management Group, LLC
Holding
CLB
+7.62%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Core Laboratories Inc (CLB) stock price today?

The current price of CLB is 13.13 USD — it has decreased -2.38

What is Core Laboratories Inc (CLB)'s business?

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

What is the price predicton of CLB Stock?

Wall Street analysts forecast CLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is11.50 USD with a low forecast of 11.50 USD and a high forecast of 11.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Core Laboratories Inc (CLB)'s revenue for the last quarter?

Core Laboratories Inc revenue for the last quarter amounts to 121.80M USD, decreased -1.45

What is Core Laboratories Inc (CLB)'s earnings per share (EPS) for the last quarter?

Core Laboratories Inc. EPS for the last quarter amounts to -0.02 USD, decreased

How many employees does Core Laboratories Inc (CLB). have?

Core Laboratories Inc (CLB) has 3300 emplpoyees as of May 11 2026.

What is Core Laboratories Inc (CLB) market cap?

Today CLB has the market capitalization of 605.25M USD.